Fundamental, thesis-driven portfolio management focused on Life Sciences companies
LifeSci Fund Management
Led by the hands-on scientific and investing experience of Portfolio Manager, Mark G. Charest, Ph.D. and leverages insights across the LifeSci Partners Platform to capture capital appreciation. Subadvisor for the AlphaCentric LifeSci Healthcare Fund, a mutual fund focused on:
- Disruptive innovation in the life sciences
- Robust cash flow / revenue growth
- Direct funding through private placements, crossovers, IPOs and other structured transactions
Mark G. Charest, Ph.D.
Founding Partner and Portfolio Manager
Mark has over 12 years of investment experience at several specialized $1B+ AUM healthcare funds.
Prior to Mark’s investment career, he led the Medicinal Chemistry Lab at Novartis Institutes for BioMedical Research where he focused on oncology drug discovery. He is the co-inventor of eight drug patents, including an FDA-approved therapeutic. Mark also served as both a Kauffman Fellow and National Science Foundation Graduate Research Fellow. He received his Ph.D. and M.S. in Chemistry and Chemical Biology from Harvard University.
- 12+ year career as an investor at several specialized $1B+ AUM healthcare funds
- Led Medicinal Chemistry Lab at the Novartis Institutes for BioMedical Research focused on Oncology drug discovery
- Co-inventor on 8 drug patents, including FDA-approved therapeutic
- Kauffman Fellow, National Science Foundation Graduate Research Fellow
- Ph.D. and M.S. in Chemistry and Chemical Biology from Harvard University
Senior Advisors
Michael Rice
Michael Rice
Michael Rice has experience in portfolio management, corporate management, investment banking and capital markets. Prior to co-founding LifeSci Advisors and LifeSci Capital, Michael was the co-head of health care investment banking at Canaccord Adams, where he was involved in debt and equity financing. Michael was also was a Managing Director at ThinkEquity Partners where he was responsible for managing Healthcare Capital Markets, which included structuring and executing numerous transactions, many of which were firsts at ThinkEquity. Prior to that, Michael served as a Managing Director at Banc of America serving large hedge funds and private equity healthcare funds. Previously, he was a Managing Director at JPMorgan/Hambrecht & Quist and Senior Managing Director at Bear Stearns.
Michael graduated from the University of Maryland with a degree in Economics and serves on the boards of Navidea (NAVD) and RDD Pharma.
3in3 LYFIX Episode 1
- Leveraging Pedigrees
- Fueling Innovation
- Mitigating Risk
Our Investment Approach
Perform systematic screening of life sciences corporate universe (500 + companies with > $1 Trillion aggregate market cap) using propriety fundamental scientific and financial analysis to identify watch list of potential investments
Perform sector diligence and gather Key Opinion Leader input via LifeSci network to identify highly innovative thematic areas of interest and disruptive growth opportunities; review financial metrics and ratios using proprietary analytics dashboard
Perform comprehensive fundamental analysis on prioritized companies using proprietary diligence methodology covering a broad range of factors, including scientific / medical evidence underlying key products, competitive landscape, regulatory strategy, market size, management team, and analyst coverage
Construct portfolio using thesis driven price targets for entry and exit. Relative risk / reward analysis guides position size and sub sector exposures: (1) Conduct ongoing contact with management teams and Key Opinion Leader community to validate ideas (2) Monitor price changes relative to operational progress and scientific / medical data releases
LifeSci Fund Management, LLC
-
250 West 55th Street
Suite 3401
New York, NY, 10019